Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06631976

Conservative Treatment in Patients With Supraspinatus Tendon Injury.

Comparison of Conservative Treatment Methods for Sleep Disorders, Pain, and Shoulder Function in Patients With Supraspinatus Tendon Injury.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Medical University of Lodz · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Rotator cuff injuries are a major cause of severe pain, often significantly impacting patients\' sleep quality. For patients waiting for surgery or those not eligible for operative treatment, conservative treatment is recommended. In cases of minor injuries, physiotherapy is as effective as surgical intervention. The aim of this study is: (1) to compare the speed, effectiveness, and durability of four implemented interventions in improving sleep quality, pain, and shoulder function, (2) to select the most optimal form of conservative treatment for patients with shoulder pain affecting sleep quality, and (3) to evaluate the expression of brain-derived neurotrophic factor (BDNF) and proBDNF (precursor) at the mRNA protein level before the planned intervention (T0), 1 month (T1), 3 months (T3), and 6 months (T6) after intervention. The study results can assist physicians and physiotherapists in providing patients with therapy that not only relieves pain and improves function but also augments sleep quality, an aspect often overlooked in the literature yet greatly impacting patients\' quality of life.

Conditions

Interventions

TypeNameDescription
DRUG1ml of Depo-Medrol® injection1ml of methylprednisolone acetate (40mg/ml) injection into subacromial bursa.
OTHERRehabilitationRehabilitation
DRUGNerve block with 4ml of 2% lidocaineNerve block with 4ml of 2% lidocaine around the suprascapular nerve
DRUGTropocells® PRP injectionTropocells® PRP injection. Patients will have an 11ml venous blood sample taken. After centrifugation, the obtained preparation will be administered to the patients intratendinously.

Timeline

Start date
2024-06-04
Primary completion
2026-05-01
Completion
2026-09-01
First posted
2024-10-08
Last updated
2025-12-10

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06631976. Inclusion in this directory is not an endorsement.